These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 21684200

  • 1. B-cell polyclonal activation and Epstein-Barr viral abortive lytic cycle are two key features in acute infectious mononucleosis.
    Al Tabaa Y, Tuaillon E, Jeziorski E, Ouedraogo DE, Bolloré K, Rubbo PA, Foulongne V, Rodière M, Vendrell JP.
    J Clin Virol; 2011 Sep; 52(1):33-7. PubMed ID: 21684200
    [Abstract] [Full Text] [Related]

  • 2. Functional Epstein-Barr virus reservoir in plasma cells derived from infected peripheral blood memory B cells.
    Al Tabaa Y, Tuaillon E, Bollore K, Foulongne V, Petitjean G, Seigneurin JM, Duperray C, Desgranges C, Vendrell JP.
    Blood; 2009 Jan 15; 113(3):604-11. PubMed ID: 18845794
    [Abstract] [Full Text] [Related]

  • 3. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
    Ladell K, Dorner M, Zauner L, Berger C, Zucol F, Bernasconi M, Niggli FK, Speck RF, Nadal D.
    Cell Microbiol; 2007 Aug 15; 9(8):2055-69. PubMed ID: 17419714
    [Abstract] [Full Text] [Related]

  • 4. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH, Wolf H, Minarovits J.
    Autoimmunity; 2008 May 15; 41(4):298-328. PubMed ID: 18432410
    [Abstract] [Full Text] [Related]

  • 5. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis).
    Tosato G, Straus S, Henle W, Pike SE, Blaese RM.
    J Immunol; 1985 May 15; 134(5):3082-8. PubMed ID: 2984282
    [Abstract] [Full Text] [Related]

  • 6. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
    Stevens SJ, Smits PH, Verkuijlen SA, Rockx DA, van Gorp EC, Mulder JW, Middeldorp JM.
    AIDS; 2007 Oct 18; 21(16):2141-9. PubMed ID: 18090040
    [Abstract] [Full Text] [Related]

  • 7. Regulatory T cell activity in primary and persistent Epstein-Barr virus infection.
    Wingate PJ, McAulay KA, Anthony IC, Crawford DH.
    J Med Virol; 2009 May 18; 81(5):870-7. PubMed ID: 19319950
    [Abstract] [Full Text] [Related]

  • 8. In vitro expansion of Epstein-Barr virus-specific HLA-restricted cytotoxic T cells direct from the blood of infectious mononucleosis patients.
    Strang G, Rickinson AB.
    Immunology; 1987 Dec 18; 62(4):647-54. PubMed ID: 2828228
    [Abstract] [Full Text] [Related]

  • 9. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT, Fernandes BJ, Mock D.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug 18; 92(2):184-93. PubMed ID: 11505266
    [Abstract] [Full Text] [Related]

  • 10. Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis.
    Tosato G, Magrath I, Koski I, Dooley N, Blaese M.
    N Engl J Med; 1979 Nov 22; 301(21):1133-7. PubMed ID: 226884
    [Abstract] [Full Text] [Related]

  • 11. Close relationship between immunoglobulin secreting-cells and Epstein-Barr virus reservoir in patients infected with HIV.
    Ouedraogo DE, Tuaillon E, Rubbo PA, Bollore K, Foulongne V, Reynes J, Vendrell JP.
    J Med Virol; 2014 Jan 22; 86(1):30-7. PubMed ID: 24114930
    [Abstract] [Full Text] [Related]

  • 12. T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis.
    Klein E, Ernberg I, Masucci MG, Szigeti R, Wu YT, Masucci G, Svedmyr E.
    Cancer Res; 1981 Nov 22; 41(11 Pt 1):4210-5. PubMed ID: 6272964
    [Abstract] [Full Text] [Related]

  • 13. Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction.
    Kurth J, Hansmann ML, Rajewsky K, Küppers R.
    Proc Natl Acad Sci U S A; 2003 Apr 15; 100(8):4730-5. PubMed ID: 12665622
    [Abstract] [Full Text] [Related]

  • 14. Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins.
    Adhikary D, Behrends U, Moosmann A, Witter K, Bornkamm GW, Mautner J.
    J Exp Med; 2006 Apr 17; 203(4):995-1006. PubMed ID: 16549597
    [Abstract] [Full Text] [Related]

  • 15. Novel method for detection of virus-specific CD41+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects.
    Piriou ER, van Dort K, Nanlohy NM, van Oers MH, Miedema F, van Baarle D.
    Eur J Immunol; 2005 Mar 17; 35(3):796-805. PubMed ID: 15724243
    [Abstract] [Full Text] [Related]

  • 16. Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy.
    Wang Y, Aïssi-Rothe L, Virion JM, De Carvalho Bittencourt M, Ulas N, Audonnet S, Salmon A, Clement L, Venard V, Jeulin H, Stoltz JF, Decot V, Bensoussan D.
    Cytotherapy; 2014 Jan 17; 16(1):122-34. PubMed ID: 24094498
    [Abstract] [Full Text] [Related]

  • 17. EBV structural antigens, gp350 and gp85, as targets for ex vivo virus-specific CTL during acute infectious mononucleosis: potential use of gp350/gp85 CTL epitopes for vaccine design.
    Khanna R, Sherritt M, Burrows SR.
    J Immunol; 1999 Mar 01; 162(5):3063-9. PubMed ID: 10072559
    [Abstract] [Full Text] [Related]

  • 18. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
    Yoshioka M, Kikuta H, Ishiguro N, Endo R, Kobayashi K.
    J Med Virol; 2003 Jul 01; 70(3):410-9. PubMed ID: 12767005
    [Abstract] [Full Text] [Related]

  • 19. Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection.
    Sugaya N, Kimura H, Hara S, Hoshino Y, Kojima S, Morishima T, Tsurumi T, Kuzushima K.
    J Infect Dis; 2004 Sep 01; 190(5):985-8. PubMed ID: 15295706
    [Abstract] [Full Text] [Related]

  • 20. Recruitment during infectious mononucleosis of CD3+CD4+CD8+ virus-specific cytotoxic T cells which recognise Epstein-Barr virus lytic antigen BHRF1.
    White CA, Cross SM, Kurilla MG, Kerr BM, Schmidt C, Misko IS, Khanna R, Moss DJ.
    Virology; 1996 May 15; 219(2):489-92. PubMed ID: 8638417
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.